State MD
Clinical Trials in Maryland
Recruiting clinical trials with at least one study location in Maryland. Data updated daily from ClinicalTrials.gov.
Top Conditions in Maryland
NCT02146170 N/A
Recruiting
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung ...
Condition
Non-Small Cell Lung Cancer
Enrollment
2,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05536141 Phase 1
Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Car...
Condition
Clear Cell Renal Cell Carcinoma
Enrollment
362 pts
Location
United States, Australia, South Korea
Sponsor
Arcus Biosciences, Inc.
NCT00001230 N/A
Recruiting
Host Response to Infection and Treatment in Filarial Diseases
Condition
Filariasis
Enrollment
500 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05966194 Phase 2
Recruiting
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radia...
Condition
Oral Mucositis
Enrollment
216 pts
Location
United States
Sponsor
EpicentRx, Inc.
NCT01834001 N/A
Recruiting
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Ther...
Condition
Prostatic Neoplasms
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05762107 Phase 2
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Condition
Type 1 Diabetes Mellitus With Hypoglycemia
Enrollment
186 pts
Location
United States, Canada
Sponsor
Zucara Therapeutics Inc.
NCT06568692 Phase 2
Recruiting
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metast...
Condition
Breast Cancer
Enrollment
90 pts
Location
United States
Sponsor
Processa Pharmaceuticals
NCT05734066 Phase 1, Phase 2
Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants Wit...
Condition
Refractory Ewing Sarcoma
Enrollment
60 pts
Location
United States, Canada
Sponsor
Jazz Pharmaceuticals
NCT06621251 Phase 2
Recruiting
Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosth...
Condition
Prosthetic Joint Infections of Hip
Enrollment
60 pts
Location
United States
Sponsor
Trellis Bioscience LLC
NCT02945501 N/A
Recruiting
Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency Dur...
Condition
Sleep Deprivation
Enrollment
40 pts
Location
United States
Sponsor
U.S. Army Medical Research and
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT06683092 N/A
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Condition
Cystic Fibrosis
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT06398639 N/A
Recruiting
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevan...
Condition
Prostate Cancer
Enrollment
1,500 pts
Location
United States
Sponsor
Adam S. Kibel, MD
NCT06159166 Phase 1, Phase 2
Recruiting
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous ...
Condition
NF1
Enrollment
24 pts
Location
United States
Sponsor
Johns Hopkins University
NCT00233272 N/A
Recruiting
Baltimore Longitudinal Study of Aging
Condition
Aging
Enrollment
10,000 pts
Location
United States
Sponsor
National Institute on Aging (N
NCT05804669 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's...
Condition
Cushing Syndrome
Enrollment
18 pts
Location
United States
Sponsor
Crinetics Pharmaceuticals Inc.
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT06151145 N/A
Recruiting
Stepped Care for Weight Loss Maintenance
Condition
Obesity
Enrollment
180 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05283720 Phase 2
Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneou...
Condition
Non-Hodgkin Lymphoma
Enrollment
496 pts
Location
United States, China, Czechia
Sponsor
Genmab
NCT02325674 N/A
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Condition
Generalised Lipodystrophy
Enrollment
100 pts
Location
United States, France, Germany
Sponsor
Amryt Pharma
NCT03294460 Phase 1
Recruiting
Nicotinic Receptor Genetic Variation and Alcohol Reward
Condition
Alcohol Drinking
Enrollment
128 pts
Location
United States
Sponsor
National Institute on Alcohol
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT04989803 Phase 1, Phase 2
Recruiting
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-...
Condition
Relapsed and/or Refractory B-cell Lymphoma
Enrollment
247 pts
Location
United States, Australia, Germany
Sponsor
Kite, A Gilead Company
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Condition
Myeloproliferative Neoplasms
Enrollment
218 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
NCT06034002 Phase 1
Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination W...
Condition
Myeloproliferative Neoplasms
Enrollment
230 pts
Location
United States
Sponsor
Incyte Corporation